Liquidia Corporation (LQDA)
| Market Cap | 316.03M |
| Revenue (ttm) | 10.38M |
| Net Income (ttm) | -39.10M |
| Shares Out | 51.98M |
| EPS (ttm) | -0.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 417,768 |
| Open | 6.00 |
| Previous Close | 6.25 |
| Day's Range | 5.66 - 6.16 |
| 52-Week Range | 2.25 - 7.16 |
| Beta | 0.24 |
| Analysts | Buy |
| Price Target | 7.75 (+27.5%) |
| Earnings Date | Nov 8, 2021 |
About LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered...
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for Liquidia stock is "Buy." The 12-month stock price forecast is 7.75, which is an increase of 27.47% from the latest price.
News
Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 Million
MORRISVILLE, N.C., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the closing of a debt facility on January 7, 2022, with Silicon Valley Bank (SVB) which provides ...
Liquidia Corporation Announces Chief Executive Officer Transition
MORRISVILLE, N.C., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and...
Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation
MORRISVILLE, N.C., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that United Therapeutics Corporation (UTC) has filed a stipulation of partial judgment with respe...
5 Penny Stocks To Buy For Under $5 Right Now
Which penny stocks are on your watch list right now? The post 5 Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Buy Now According To Insiders In November 2021
Hot penny stocks insiders are buying in November The post 5 Penny Stocks To Buy Now According To Insiders In November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock...
Best Penny Stocks To Buy With A Full-Time Job? 5 Hit It Big In Q4 2021
Can you make money in the stock market with a full time job? The post Best Penny Stocks To Buy With A Full-Time Job?
Liquidia to Participate in the Jefferies London Healthcare Conference
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Michael Kaseta, Chief Financial Officer of Liquidia, will provide an update on the compa...
FDA Grants Tentative Approval for Liquidia's YUTREPIA™ (Treprostinil) Inhalation Powder
MORRISVILLE, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) granted tentative approval for YUTREPIA™ (trepro...
Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -16.67% and 28.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th...
Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update
- Increased adoption of generic Treprostinil Injection by patients, physicians and payers - Completed on-site pre-approval inspections by FDA of two U.S. manufacturing facilities - Anticipate FDA ...
4 Top Penny Stocks To Watch After FOMC Meeting In November
4 penny stocks to watch this week. The post 4 Top Penny Stocks To Watch After FOMC Meeting In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Watch For November With Potential Biotech Catalysts
Biotech penny stocks to watch with upcoming events this week. The post 5 Penny Stocks To Watch For November With Potential Biotech Catalysts appeared first on Penny Stocks to Buy, Picks, News and Inform...
Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes Review ...
Liquidia to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
MORRISVILLE, N.C., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Damian deGoa, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Glob...
FDA Completes On-site Pre-Approval Inspection of Liquidia's Morrisville, North Carolina Facility
No Form 483 observations were issued during 5-day inspection No Form 483 observations were issued during 5-day inspection
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 18.75% and 95.94%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Liquidia: Q2 Earnings Insights
Shares of Liquidia (NASDAQ:LQDA) fell 0.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 73.47% year over year to ($0.13), which beat the estimat...
Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the quarter ended June 30, 2021. The Company w...
Liquidia to Report Second Quarter 2021 Financial Results on August 10, 2021
MORRISVILLE, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2021 financial results on Tuesday, August 10, 2021. The co...
Liquidia Announces FDA Acceptance of New Drug Application Resubmission for LIQ861 (treprostinil) Inhalation Powder
MORRISVILLE, N.C., June 02, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resu...
Liquidia Corporation To Present At The Jefferies Virtual Healthcare Conference
MORRISVILLE, N.C., May 26, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian deGoa, Chief Executive Officer of Liquidia, will provide an overview and update on...
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
Sandoz Generic Treprostinil Injection now available for both routes of administration, subcutaneous and intravenous Sandoz Generic Treprostinil Injection now available for both routes of administration,...
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -5.00% and 260.28%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the st...
Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate Update
- Doubled the market opportunity for Treprostinil Injection by adding subcutaneous delivery - Resubmitted New Drug Application for LIQ861 (treprostinil) Inhalation Powder - Improved financial position w...